Four Penny Stocks Soar Over 100% in 2025, Outshining Nifty

STOCK-INVESTMENT-IDEAS
Whalesbook Logo
AuthorVihaan Mehta|Published at:
Four Penny Stocks Soar Over 100% in 2025, Outshining Nifty
Overview

Indian equities concluded 2025 with a decade-long Nifty winning streak, gaining 10.7%. However, the year was marked by resilience amid domestic and global challenges, causing Indian markets to lag peers. Amidst this, four penny stocks under Rs 100 delivered spectacular returns, with Shukra Pharma surging 314% on strong financial results and a robotics MoU. GRM Overseas, AB Infrabuild, and Arfin India also posted gains exceeding 100% due to FII interest, corporate actions, and major orders.

Nifty Posts Modest 2025 Gains Amid Global Headwinds

Indian equity markets closed 2025 with the benchmark Nifty achieving its tenth consecutive year of gains, albeit with a subdued 10.7% rise. The year was characterized by resilience rather than aggressive outperformance, as domestic challenges and global economic pressures caused Indian equities to trail many international and emerging market peers. Despite the broader market's tempered performance, a select group of smaller companies delivered exceptional returns.

Shukra Pharma Leads Penny Stock Rally

Shukra Pharma, a pharmaceutical manufacturer, emerged as a standout performer, rallying an impressive 314% in 2025. Its stock price climbed from ₹14.3 on January 1 to ₹59.3 by December 31. This surge was fueled by strong year-on-year financial improvements, with June quarter revenue up nearly 69% and net profit doubling. The September quarter continued the trend with significant profit growth. Further boosting investor confidence, Shukra Pharma's subsidiary signed an MoU with US-based Borns Medical Robotics Inc. to introduce AI-enabled surgical robotic systems in India and select South Asian markets.

GRM Overseas Attracts FIIs and Declares Bonus

GRM Overseas, a basmati rice miller and marketer, saw its stock price jump 143% in 2025, from ₹66.73 to ₹162.1. Foreign Institutional Investors (FIIs) increased their stake significantly throughout the year, rising from 0.17% to 3.36%. The company's board also approved a 2:1 bonus share issue in December 2025. GRM Overseas projects substantial revenue growth, expecting its India business revenue to rise from ₹5.4 billion in FY25 to ₹20 billion by FY28.

AB Infrabuild Secures Key Infrastructure Orders

Engaged in civil construction for railways, roads, and dams, AB Infrabuild's stock gained 107% in 2025, moving from ₹8.6 to ₹17.9. The company executed a stock split, reducing its share face value from ₹10 to ₹1. A significant domestic order worth ₹520.8 million from East Coast Railways, Indian Railways, to be executed over 24 months, further bolstered its prospects. The company is focused on expanding its operational reach and capabilities.

Arfin India Wins Major Metals Order

Arfin India, a non-ferrous metals manufacturer, posted a 104% gain in 2025, with its stock price moving from ₹35.9 to ₹73.3. FIIs added a 0.2% stake in the company during the September quarter. In December 2025, Arfin India secured a substantial order worth ₹3,210 million from Diamond Power Infrastructure Limited for aluminium conductors, involving the supply of 11,000 metric tonnes over 11 months. The company plans capacity expansion and new product launches.

Caution Advised for Penny Stock Investors

While these penny stocks delivered exceptional returns, investing in them based solely on past performance carries substantial risk. Their high volatility, potential lack of liquidity, and weaker financial fundamentals make them speculative. Investors are advised to prioritize thorough due diligence, examining company fundamentals, corporate governance, and valuations, and consider diversified portfolios for long-term wealth creation.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.